Paper17599300
Invasive Klebsiella pneumoniae syndrome in North America.
Nadasy KA and 2 others. Clin Infect Dis, 2007. Cited by 136 papers, by iCite.
Cite this record
ConductScience Library. Invasive Klebsiella pneumoniae syndrome in North America. Papers, record 17599300. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17599300
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Proteins | Major topic |
| Klebsiella Infections | Major topic |
| Klebsiella pneumoniae | Major topic |
| Liver Abscess | Major topic |
| Asian People | |
| Diabetes Mellitus, Type 2 | |
| Gene Amplification | |
| Humans | |
| Male | |
| Middle Aged | |
| North America | |
| Syndrome | |
| Texas |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00895089 | Moxifloxacin Versus Ceftriaxone in the Treatment of Primary Pyogenic Liver Abscess | Background |
Source ClinicalTrials.gov
Cited by87
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 136 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42505139 | Hypermucoviscosity in Klebsiella pneumoniae: manifestation, regulation, and roles in pathogenesis. | J Bacteriol | 2026 | https://conductscience.org/library/papers/42505139 | PubMed |
| 42186451 | Hypervirulent and Drug-Resistant Klebsiella pneumoniae: Clinical Challenges and Alternative Treatment Strategies. | Int J Gen Med | 2026 | https://conductscience.org/library/papers/42186451 | PubMed |
| 41753620 | Resistance, Virulence, and Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Causing Bloodstream Infections in Saudi Arabia. | Microorganisms | 2026 | https://conductscience.org/library/papers/41753620 | PubMed |
| 40868793 | Photoactive Hydrogels as Materials for Biological Applications: Preparation of Thermally Stable Photoactive Films. | Gels | 2025 | https://conductscience.org/library/papers/40868793 | PubMed |
| 40757871 | Hypervirulent Klebsiella pneumoniae causing bloodstream infections in Hungary. | Microbiol Spectr | 2025 | https://conductscience.org/library/papers/40757871 | PubMed |
| 40474116 | Prevalence and molecular characterisation of multi-drug resistant ST11 hypervirulent Klebsiella pneumoniae in a teaching hospital. | BMC Microbiol | 2025 | https://conductscience.org/library/papers/40474116 | PubMed |
| 40430542 | Hypervirulent Klebsiella pneumoniae: Insights into Virulence, Antibiotic Resistance, and Fight Strategies Against a Superbug. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40430542 | PubMed |
| 40363031 | Design, Characterization, and Preparation of New Smart Photoactive Polymers and Their Capacity for Photodynamic Antimicrobial Action in Organic Film. | Polymers (Basel) | 2025 | https://conductscience.org/library/papers/40363031 | PubMed |
| 39858330 | Immunomodulatory Effect of Phage Depolymerase Dep_kpv74 with Therapeutic Potential Against K2-Hypervirulent Klebsiella pneumoniae. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/39858330 | PubMed |
| 39770672 | Phenotypic and Genotypic Detection of Hypervirulent Klebsiella pneumoniae Isolated from Hospital-Acquired Infections. | Microorganisms | 2024 | https://conductscience.org/library/papers/39770672 | PubMed |
| 39705367 | A bacterial methyltransferase that initiates biotin synthesis, an attractive anti-ESKAPE druggable pathway. | Sci Adv | 2024 | https://conductscience.org/library/papers/39705367 | PubMed |
| 39263100 | Molecular characterization of superbugs K. pneumoniae harboring extended-spectrum β-lactamase (ESBL) and carbapenemase resistance genes among hospitalized patients in southwestern Iran, Western Asia. | Heliyon | 2024 | https://conductscience.org/library/papers/39263100 | PubMed |
| 38800315 | Prognosis and Characteristics of Hypermucoviscous Klebsiella pneumoniae Infection in Critically Ill Patients: A Case Series. | Cureus | 2024 | https://conductscience.org/library/papers/38800315 | PubMed |
| 38698788 | Molecular detection of Class 1, 2, and 3 integrons in hypervirulent and classic Klebsiella pneumoniae isolates: A cross-sectional study. | Health Sci Rep | 2024 | https://conductscience.org/library/papers/38698788 | PubMed |
| 38660055 | Virulence Factors and Carbapenem-Resistance Mechanisms in Hypervirulent Klebsiella Pneumoniae. | Infect Drug Resist | 2024 | https://conductscience.org/library/papers/38660055 | PubMed |
| 37711882 | Liver, lung, muscle, and bone: Klebsiella pneumoniae invasive liver abscess syndrome in a Vietnamese immigrant. | IDCases | 2023 | https://conductscience.org/library/papers/37711882 | PubMed |
| 36985277 | Occurrence and Molecular Study of Hypermucoviscous/Hypervirulence Trait in Gut Commensal K. pneumoniae from Healthy Subjects. | Microorganisms | 2023 | https://conductscience.org/library/papers/36985277 | PubMed |
| 36985234 | Antimicrobial Resistance Pattern, Pathogenicity and Molecular Properties of Hypervirulent Klebsiella pneumonia (hvKp) among Hospital-Acquired Infections in the Intensive Care Unit (ICU). | Microorganisms | 2023 | https://conductscience.org/library/papers/36985234 | PubMed |
| 36932105 | Virulence analysis and antibiotic resistance of Klebsiella pneumoniae isolates from hospitalised patients in Poland. | Sci Rep | 2023 | https://conductscience.org/library/papers/36932105 | PubMed |
| 36853006 | Emergence of Carbapenemase-Producing Hypervirulent Klebsiella pneumoniae in Switzerland. | Antimicrob Agents Chemother | 2023 | https://conductscience.org/library/papers/36853006 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17599300
GET https://conductscience.org/api/papers/v1/17599300/cited_by?page=2